Cargando…

OR28-6 Short-Term Mifepristone Treatment Improves Hepatic and Adipose Tissue Insulin Sensitivity in Overweight and Obese Subjects with Glucose Intolerance

Background: Increased tissue cortisol availability and enhanced glucocorticoid action have been implicated in abnormal glucose and fat metabolism in patients with obesity, metabolic syndrome, and type 2 diabetes. Objective: To test the hypothesis that blockade of glucocorticoid receptor (GR) with mi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grewal, Shivraj, Sharma, Susmeeta, McGlotten, Raven, Muniyappa, Ranganath, Nieman, Lynnette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Diabetes Mellitus and Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554765/ http://dx.doi.org/10.1210/js.2019-OR28-6

Ejemplares similares

SAT-624 Predictive Ability of Lipoprotein Insulin Resistance (LPIR) Score in South Asians: A Comparison of Surrogate Indices of Insulin Sensitivity/Resistance
por: Fosam, Andin, et al.
Publicado: (2020)

OR08-05 Sex and Ethnic Differences in Advanced Lipoprotein Profiles in South Asians, African-Americans, and Caucasians
por: Sarcone, Camila, et al.
Publicado: (2020)

OR31-6 Insulin Sensitivity and Pancreatic Beta-Cell Function in Patients with Primary Aldosteronism
por: Grewal, Shivraj, et al.
Publicado: (2019)

SAT-651 Ethnic Differences in the Relationship Between Uric Acid Clearance and Insulin Sensitivity
por: Armiyaw, Abdul-Latif, et al.
Publicado: (2020)

Insulin Resistant Gestational Glucose Intolerance Is Associated With Adverse Perinatal Outcomes
por: Selen, Daryl J, et al.
Publicado: (2021)

THU269 Ethnic Differences In Hepatic Insulin Clearance: A Cross-Sectional Study Comparing South Asians And Non-Hispanic Whites
por: Ramanathan, Amrita L, et al.
Publicado: (2023)

MON-LB116 FGF-21 Is A Reliable Marker Of Insulin Resistance Before The Occurrence Of Glucose Intolerance
por: sawah, ahmed, et al.
Publicado: (2020)

SAT-623 Glucose Intolerance Modifies the Association Between Insulin-Like Growth Factor-1 and All-Cause Mortality
por: Visaria, Aayush, et al.
Publicado: (2020)

OR28-1 Role of Mineralocorticoid Receptor in Metabolic Syndrome
por: Ferguson, Daniel, et al.
Publicado: (2019)

SAT-LB032 Young Adult LEW.1WR1 Rats Develop Increased Glucose Intolerance on a Moderately Increased Sucrose Diet
por: Collins, Genoah, et al.
Publicado: (2019)

OR28-4 Spontaneous Autoimmune Diabetes in Humanized Mice Carrying Human Type 1 Diabetes Susceptibility
por: Imam, Shahnawaz, et al.
Publicado: (2019)

OR28-5 Bile Acid Sequestration Accelerates Glucagon Receptor-Mediated Body Weight Loss in Obese Mice
por: Kim, Teayoun, et al.
Publicado: (2019)

OR28-2 The Ldb1 Transcriptional Co-regulator Is Required for Establishment, Development, and Survival of the Pancreatic Endocrine Lineage
por: Toren, Eliana, et al.
Publicado: (2019)

OR26-03 Lower Serum Myostatin Levels Are Associated with Higher Insulin Sensitivity in Adults with Overweight/Obesity
por: Haines, Melanie S, et al.
Publicado: (2020)

SAT163 Title: Adult-onset Hyperinsulinemic Hypoglycemia Due To An Activating Mutation In Glucokinase
por: Vaid, Sonal, et al.
Publicado: (2023)

OR14-2 Liraglutide Treatment in Overweight and Obese Patients with Type 1 Diabetes: A 26 weeks Randomized Controlled Trial
por: Dandona, Paresh, et al.
Publicado: (2019)

Characterization of Viral Insulin-Like Peptides Reveals Unique White Adipose Tissue Specific Characteristics
por: Chrudinova, Martina, et al.
Publicado: (2021)

FRI099 Advanced Lipoprotein Analysis In Patients With Cushing’s Syndrome
por: Varghese, Ron T, et al.
Publicado: (2023)

OR28-3 A Mutation in KCNK16 Segregating with Autosomal Dominant Non-Ketotic Diabetes Drastically Increases TALK-1 Membrane Current: A Novel Gene for MODY?
por: Johnson, Stephanie, et al.
Publicado: (2019)

Evaluation of the Prognostic Significance of Adipose Tissue Hormones in the Development of Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus
por: Kyryliuk, Mykhailo L, et al.
Publicado: (2021)

MON-167 Use of a Morning Cortisol Level to Predict Recovery of the Hypothalamic-Pituitary-Adrenal (HPA) Axis in Secondary Adrenal Insufficiency Following Remission of Cushing’s Syndrome
por: McGlotten, Raven, et al.
Publicado: (2020)

THU039 Use Of Desmopressin In The Differential Diagnosis Of Cushing’s Syndrome: Recent Experience At The NIH
por: McGlotten, Raven, et al.
Publicado: (2023)

SUN-368 Fatty Hypertrophy of the Hip as a Clinical Manifestation of Cushing Syndrome
por: McGlotten, Raven, et al.
Publicado: (2019)

MON-662 Diabetes Risk for Non-Obese Subjects in a Japanese Population
por: Tatsukawa, Yoshimi, et al.
Publicado: (2020)

MON-LB031 Higher Insulin Degrading Enzyme Levels in Subjects with Metabolic Syndrome
por: Sofer, Yael, et al.
Publicado: (2019)

SUN-133 Glycemic Control in T1D Subjects before and after Pancreas Transplantation
por: Dadlani, Vikash, et al.
Publicado: (2019)

The Ratio of Unsaturated to Saturated Fatty Acids is a Distinguishing Feature of NAFLD in Subjects With Metabolic Disease
por: Falcone, John N, et al.
Publicado: (2021)

Effects of Evogliptin as Add on in Type 2 Diabetes (T2DM) Subjects Inadequately Controlled With Metformin and Glimepiride Combination
por: Guha, Shaibal
Publicado: (2021)

SUN-156 Exosomal MicroRNA Profile in Korean Obese Subjects with Prediabetes and Those with Type 2 Diabetes Mellitus
por: Park, Hyeong-Kyu, et al.
Publicado: (2019)

Comparison Between Linagliptin and Canagliflozin Effect on Inflammatory Markers, CD34+ Cell Gene Expression and Urine Exosomes in Type 2 Diabetes Subjects
por: Nandula, Seshagiri R, et al.
Publicado: (2021)

OR26-07 Mild Physiologic Hyperglycemia Does Not Affect Glucose Mediated but Impairs Insulin-Mediated Suppression of Plasma Glucagon in Healthy Normal Glucose Tolerant Subjects
por: Tripathy, Devjit, et al.
Publicado: (2020)

MON-179 Repeat BCG Vaccination Creates Lasting HbA1c Reductions in Adult Subjects with Longstanding Type 1 Diabetes by Correcting Immune-Metabolic Defects
por: Faustman, Denise, et al.
Publicado: (2019)

SAT-449 Factors Associated with Reduced Thyroid Hormones in Cushing Syndrome Patients Before and After Surgical Cure
por: Shekhar, Skand, et al.
Publicado: (2020)

Assessment of Chronic Supraphysiological Glucocorticoid Dosing Needs of Patients With Adrenal Insufficiency
por: Mun, Jeff, et al.
Publicado: (2021)

THU030 Evaluation Of Combined CRH And HDDST Test Performance
por: Elenius, Henrik, et al.
Publicado: (2023)

SAT-LB031 Empagliflozin as an Add-On Medication to Subjects Uncontrolled on DPP4 Inhibitors and Metformin: Real World Data Supporting the Use of Empagliflozin as a Rational Second Add-On in Indian Type 2 Diabetic Patients
por: MS, ANEESH
Publicado: (2019)

MON-444 Defining Remission In Cushing Syndrome After Tumor Resection In Cases Of Non-suppressed Postoperative Serum Cortisol Levels
por: McGlotten, Raven, et al.
Publicado: (2019)

SUN-355 Computed Tomography Appearance of Adrenal Glands in Non-Adrenal Causes of Cushing's Syndrome
por: Bansal, Rashika, et al.
Publicado: (2019)

SAT-459 Hypothalamic-Pituitary-Gonadal (HPG) and Hypothalamic-Pituitary-Thyroid (HPT) Axes in Cushing Syndrome (CS): A Retrospective Cohort Study
por: Shekhar, Skand, et al.
Publicado: (2019)

MON-178 Cyclical Cushing’s Syndrome in 12 Patients with Ectopic ACTH Secretion
por: Zenno, Anna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k9qgi6m4iv0mkf96fjd6650bbh